The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy

od Paolicelli, Damiano, Iannazzo, Sergio, Santoni, Laura, Iaffaldano, Antonio, Di Lecce, Valentina, Manni, Alessia, Lavolpe, Vito, Tortorella, Carla, D'Onghia, Mariangela, Direnzo, Vita, Puma, Elisa, Trojano, Maria
Wydane w PLoS One (2016)